Cyclosporin A in combination with HAART in primary HIV-1 infection

G. P. Rizzardi, M. Vaccarezza, B. Capiluppi, G. Tambussi, A. Lazzarin, G. Pantaleo

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

HAART is the cornerstone of HIV therapy, and has significantly reduced morbidity and mortality associated with HIV disease. The institution of HAART during the primary HIV-1 infection has a more profound influence on the ultimate pattern and rate of disease progression than therapy commenced later on. However, it also well demonstrated that HAART alone is not able to eradicate the virus, unless over a life-long period of time. There is therefore the need to develop alternative strategies aimed at modulating the immune responses in order to achieve the long-term control of HIV even once HAART is discontinued. Among immunomodulant agents, cyclosporin A in combination with HAART might play a role in the treatment of people with primary HIV-1 infection.

Original languageEnglish
Pages (from-to)79-81
Number of pages3
JournalJournal of Biological Regulators and Homeostatic Agents
Volume14
Issue number1
Publication statusPublished - 2000

Fingerprint

cyclosporine
Highly Active Antiretroviral Therapy
Human immunodeficiency virus 1
Cyclosporine
HIV Infections
HIV-1
therapeutics
disease course
infection
morbidity
HIV
immune response
viruses
Disease Progression
Therapeutics
Viruses
Morbidity
Mortality

Keywords

  • Cyclosporin A
  • HAART
  • HIV eradication
  • Immune-based strategies
  • Immunosuppression
  • Primary HIV-1 infection

ASJC Scopus subject areas

  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Physiology (medical)
  • Medicine (miscellaneous)
  • Physiology
  • Agricultural and Biological Sciences(all)

Cite this

Rizzardi, G. P., Vaccarezza, M., Capiluppi, B., Tambussi, G., Lazzarin, A., & Pantaleo, G. (2000). Cyclosporin A in combination with HAART in primary HIV-1 infection. Journal of Biological Regulators and Homeostatic Agents, 14(1), 79-81.

Cyclosporin A in combination with HAART in primary HIV-1 infection. / Rizzardi, G. P.; Vaccarezza, M.; Capiluppi, B.; Tambussi, G.; Lazzarin, A.; Pantaleo, G.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 14, No. 1, 2000, p. 79-81.

Research output: Contribution to journalArticle

Rizzardi, GP, Vaccarezza, M, Capiluppi, B, Tambussi, G, Lazzarin, A & Pantaleo, G 2000, 'Cyclosporin A in combination with HAART in primary HIV-1 infection', Journal of Biological Regulators and Homeostatic Agents, vol. 14, no. 1, pp. 79-81.
Rizzardi, G. P. ; Vaccarezza, M. ; Capiluppi, B. ; Tambussi, G. ; Lazzarin, A. ; Pantaleo, G. / Cyclosporin A in combination with HAART in primary HIV-1 infection. In: Journal of Biological Regulators and Homeostatic Agents. 2000 ; Vol. 14, No. 1. pp. 79-81.
@article{ff263a2ab6344f4986dd8f59db03d752,
title = "Cyclosporin A in combination with HAART in primary HIV-1 infection",
abstract = "HAART is the cornerstone of HIV therapy, and has significantly reduced morbidity and mortality associated with HIV disease. The institution of HAART during the primary HIV-1 infection has a more profound influence on the ultimate pattern and rate of disease progression than therapy commenced later on. However, it also well demonstrated that HAART alone is not able to eradicate the virus, unless over a life-long period of time. There is therefore the need to develop alternative strategies aimed at modulating the immune responses in order to achieve the long-term control of HIV even once HAART is discontinued. Among immunomodulant agents, cyclosporin A in combination with HAART might play a role in the treatment of people with primary HIV-1 infection.",
keywords = "Cyclosporin A, HAART, HIV eradication, Immune-based strategies, Immunosuppression, Primary HIV-1 infection",
author = "Rizzardi, {G. P.} and M. Vaccarezza and B. Capiluppi and G. Tambussi and A. Lazzarin and G. Pantaleo",
year = "2000",
language = "English",
volume = "14",
pages = "79--81",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "1",

}

TY - JOUR

T1 - Cyclosporin A in combination with HAART in primary HIV-1 infection

AU - Rizzardi, G. P.

AU - Vaccarezza, M.

AU - Capiluppi, B.

AU - Tambussi, G.

AU - Lazzarin, A.

AU - Pantaleo, G.

PY - 2000

Y1 - 2000

N2 - HAART is the cornerstone of HIV therapy, and has significantly reduced morbidity and mortality associated with HIV disease. The institution of HAART during the primary HIV-1 infection has a more profound influence on the ultimate pattern and rate of disease progression than therapy commenced later on. However, it also well demonstrated that HAART alone is not able to eradicate the virus, unless over a life-long period of time. There is therefore the need to develop alternative strategies aimed at modulating the immune responses in order to achieve the long-term control of HIV even once HAART is discontinued. Among immunomodulant agents, cyclosporin A in combination with HAART might play a role in the treatment of people with primary HIV-1 infection.

AB - HAART is the cornerstone of HIV therapy, and has significantly reduced morbidity and mortality associated with HIV disease. The institution of HAART during the primary HIV-1 infection has a more profound influence on the ultimate pattern and rate of disease progression than therapy commenced later on. However, it also well demonstrated that HAART alone is not able to eradicate the virus, unless over a life-long period of time. There is therefore the need to develop alternative strategies aimed at modulating the immune responses in order to achieve the long-term control of HIV even once HAART is discontinued. Among immunomodulant agents, cyclosporin A in combination with HAART might play a role in the treatment of people with primary HIV-1 infection.

KW - Cyclosporin A

KW - HAART

KW - HIV eradication

KW - Immune-based strategies

KW - Immunosuppression

KW - Primary HIV-1 infection

UR - http://www.scopus.com/inward/record.url?scp=0034457544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034457544&partnerID=8YFLogxK

M3 - Article

C2 - 10763900

AN - SCOPUS:0034457544

VL - 14

SP - 79

EP - 81

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 1

ER -